Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinepazide maleate injection for acute ischemic stroke
ChiCTR-IIR-16008180Phase 4Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cinepazide in ischemic stroke (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: NIHSS responder rate at 90 days. Started Mar 2016; status: recruiting.
02
Drugs
cinepazide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-IIR-16008180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16008180.